Bright Minds Biosciences DRUG
NASDAQ DRUG
$50.44 -4.76 (-8.62%)
At close: Oct 21, 2026 · 4:00 PM EDT

Bright Minds Biosciences (DRUG) Payables (2020 - 2026)

Updated

Bright Minds Biosciences (DRUG) reported Payables of $1.79 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 371.2% from $380,200 a year earlier but down 34.5% from the prior quarter.

Analysis

Bright Minds Biosciences (DRUG) Payables (2020 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Bright Minds Biosciences posted Payables of $1.61 million, up 387.5% from FY2024.

  • Payables has a five-year compound annual growth rate of 70.3% (FY2020 to FY2025).
  • By fiscal year, Payables came in at $330,326 in FY2024 (+114.8%), $153,757 in FY2023 (-86.0%), $1.1 million in FY2022 (+117.8%) and $505,261 in FY2021 (+350.0%).
  • Five-year quarterly Payables spans a low of $120,355 in fiscal Q3 2024 and a high of $2.73 million in fiscal Q2 2026.
  • Year over year, Payables has now increased in each of the last five quarters, with growth averaging 236.8% over the last eight quarters.
  • The high point for year-over-year Payables in five years was fiscal Q2 2026 (growth of 600.5%); the low point was fiscal Q4 2023 (a decline of 85.6%).
  • Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $2.73 million (Q2 2026), $1.07 million (Q1 2026) and $1.64 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 6.11 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 20.92 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 33.30 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 5.96 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 4.26 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 22.89 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 2.87 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 674.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 7.03 Bn
10 Bright Minds Biosciences 343.90 Mn -219.69 Mn - 1.74 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.74 Mn
Mar 31, 2026 2.69 Mn
Dec 31, 2025 1.09 Mn
Sep 30, 2025 1.62 Mn
Jun 30, 2025 385,050.51
Mar 31, 2025 391,510.31
Dec 31, 2024 270,984.25
Sep 30, 2024 332,597.28
Jun 30, 2024 120,160.89
Mar 31, 2024 599,183.64
Dec 31, 2023 604,399.95
Sep 30, 2023 153,663.18
Jun 30, 2023 485,587.89
Mar 31, 2023 689,399.43
Dec 31, 2022 338,091.77
Sep 30, 2022 1.03 Mn
Jun 30, 2022 299,087.98
Mar 31, 2022 803,950.39
Dec 31, 2021 384,165.57
Sep 30, 2021 500,692.34
API Access

Bright Minds Biosciences Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=payables&ticker=DRUG&period=max&api_key=YOUR_API_KEY